# A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies

> **NCT01054352** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 182 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** JNJ38224342
- **DRUG:** JNJ38224342/placebo
- **DRUG:** JNJ38224342/placebo
- **DRUG:** JNJ38224342/placebo

## Key facts

- **NCT ID:** NCT01054352
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** —
- **Final completion:** 2011-03
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01054352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01054352, "A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01054352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*